Does TOFACITINIB Cause Angioedema? 68 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Angioedema have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.0% of all adverse event reports for TOFACITINIB.
68
Reports of Angioedema with TOFACITINIB
0.0%
of all TOFACITINIB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Angioedema From TOFACITINIB?
Of the 68 reports, 11 (16.2%) required hospitalization, and 4 (5.9%) were considered life-threatening.
Is Angioedema Listed in the Official Label?
Yes, Angioedema is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Angioedema?
LISINOPRIL (5,370)
IBUPROFEN (2,507)
OMALIZUMAB (1,650)
ACETAMINOPHEN (1,152)
RAMIPRIL (1,130)
AMOXICILLIN (943)
ASPIRIN (820)
CETIRIZINE (766)
DICLOFENAC (766)
SACUBITRIL\VALSARTAN (730)
Which TOFACITINIB Alternatives Have Lower Angioedema Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN